CO-DIAGNOSTICS INC's ticker is CODX and the CUSIP is 189763105. A total of 87 filers reported holding CO-DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 1.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154,359 | -4.5% | 145,621 | 0.0% | 0.00% | – |
| Q2 2023 | $161,640 | -25.0% | 145,621 | 0.0% | 0.00% | – |
| Q1 2023 | $215,519 | -53.5% | 145,621 | -20.9% | 0.00% | – |
| Q4 2022 | $463,811 | -39.1% | 184,052 | -22.6% | 0.00% | – |
| Q3 2022 | $762,000 | -39.2% | 237,675 | +6.4% | 0.00% | – |
| Q2 2022 | $1,253,000 | -11.2% | 223,349 | -2.1% | 0.00% | – |
| Q1 2022 | $1,411,000 | -15.1% | 228,232 | +22.6% | 0.00% | – |
| Q4 2021 | $1,662,000 | +0.1% | 186,208 | +9.2% | 0.00% | – |
| Q3 2021 | $1,660,000 | +36.3% | 170,568 | +15.5% | 0.00% | – |
| Q2 2021 | $1,218,000 | -17.9% | 147,672 | -5.1% | 0.00% | – |
| Q1 2021 | $1,484,000 | +6.5% | 155,561 | +3.9% | 0.00% | – |
| Q4 2020 | $1,393,000 | +2.9% | 149,755 | +50.3% | 0.00% | – |
| Q3 2020 | $1,354,000 | -29.4% | 99,664 | +0.5% | 0.00% | -100.0% |
| Q2 2020 | $1,919,000 | +1858.2% | 99,186 | +671.0% | 0.00% | – |
| Q1 2020 | $98,000 | – | 12,864 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Koss-Olinger Consulting, LLC | 111,808 | $119,000 | 0.02% |
| Physician Wealth Advisors, Inc. | 39,375 | $40,950 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 272,900 | $289,274 | 0.01% |
| Aristides Capital LLC | 15,000 | $15,900 | 0.01% |
| XTX Topco Ltd | 21,763 | $23,069 | 0.00% |
| Portside Wealth Group, LLC | 12,000 | $13,000 | 0.00% |
| Engineers Gate Manager LP | 13,309 | $14,108 | 0.00% |
| Renaissance Technologies | 636,400 | $675 | 0.00% |
| Kestra Advisory Services, LLC | 128,560 | $136,274 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 4,000 | $4,240 | 0.00% |